Learn More
PURPOSE To assess CA-125 as a measure of response in patients treated with paclitaxel. PATIENTS AND METHODS One hundred forty-four patients treated with paclitaxel derived from four different(More)
A number of studies have suggested that serum CA 125 levels may be an important prognostic factor for survival of patients with ovarian carcinoma. We investigated, in a large group of patients from(More)
BACKGROUND There is no clear data on the optimum number of courses of platinum chemotherapy required for treating advanced ovarian cancer. A prospective randomised trial was performed to compare five(More)